Work Here?
Overview
Henry Meds delivers weight-loss programs through telehealth with licensed providers using a HIPAA-compliant platform called Doxy. Patients complete a medical history and receive a personalized plan that includes medication, delivered without injections or in-person visits. The program combines provider consultations and medication at transparent, upfront pricing with no hidden fees or long-term contracts, emphasizing easy access and affordability. The goal is to make effective weight loss accessible and convenient for a wide audience by offering remote care and included medications.
About Henry Meds
Industries
Healthcare
Company Size
51-200
Company Stage
Seed
Total Funding
N/A
Headquarters
San Francisco, California
Founded
2022
Get referred to Henry Meds
See people who can refer or advise you
Simplify's Take
What believers are saying
- Forbes reported Henry Meds covered 40 states and Washington, D.C. on April 22, 2026.
- Its August 2026 tirzepatide launch matches demand for needle-free weight-loss treatments.
- FDA shortages eased by 2026, pushing patients toward telehealth alternatives with faster access.
What critics are saying
- FDA's August 31, 2026 GLP-1 warning intensifies scrutiny on compounded semaglutide and tirzepatide.
- Henry Meds depends on compounds FDA says lack premarket review and quality validation.
- If Eli Lilly and Novo Nordisk restrict supply and pharmacy compounding, Henry Meds loses its core product.
What makes Henry Meds unique
- Henry Meds sells all-in weight-loss pricing with no separate membership fee in 2026.
- Its August 2026 tirzepatide page offers compounded oral dissolving tablets, rare among telehealth rivals.
- The company keeps care online through licensed providers and state-specific, individualized prescriptions.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Unlimited Paid Time Off
Remote Work Options
Performance Bonus
Growth & Insights and Company News
6 month growth
↓ -7%1 year growth
↓ -3%2 year growth
↑ 7%Telehealth company Henry Meds, known for its commitment to patient-centric care, announced the launch of Compounded Oral Dissolving Tirzepatide Tablets.
There are no jobs for Henry Meds right now.
Find jobs on Simplify and start your career today
About Henry Meds
Industries
Healthcare
Company Size
51-200
Company Stage
Seed
Total Funding
N/A
Headquarters
San Francisco, California
Founded
2022
There are no jobs for Henry Meds right now.
Find jobs on Simplify and start your career today